"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)

Heather L. Stuckey; Michael Vallis; Katharina Kovacs Burns; Christine B. Mullan-Jensen; Jean M. Reading; Sanjay Kalra; Johan Wens; Andrzej Kokoszka; Søren E. Skovlund; Mark Peyrot

doi:10.1016/j.clinthera.2015.06.010

"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)

Heather L. Stuckey, Michael Vallis, Katharina Kovacs Burns, Christine B. Mullan-Jensen, Jean M. Reading, Sanjay Kalra, Johan Wens, Andrzej Kokoszka, Søren E. Skovlund, Mark Peyrot

Medicine

Medicine

Research output: Contribution to journal › Article › peer-review

43 Citations (Scopus)

Abstract

Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who "tells" to one who "listens" to PWD. Some ways that HCPs can "listen" to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.

Original language	English
Article number	2620
Pages (from-to)	1986-1998.e12
Journal	Clinical Therapeutics
Volume	37
Issue number	9
DOIs	https://doi.org/10.1016/j.clinthera.2015.06.010
Publication status	Published - Sept 1 2015

Bibliographical note

Funding Information:
Novo Nordisk Inc funded the DAWN2 study. Dr. Stuckey has received compensation from Novo Nordisk for developing the DAWN2 coding scheme, training/supervising coders, and conducting qualitative analysis, as well as travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Vallis has received research funding from AbbVie Inc and Pfizer Inc, and speaking honoraria from AbbVie; Bayer Pharmaceuticals Corp; Becton, Dickinson, and Co; Merck & Co, Inc; Novo Nordisk; and The Sanofi-Aventis Group. Dr. Burns has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Mullan-Jensen’s salary is paid by Novo Nordisk A/S, Copenhagen, Denmark. Ms. Reading has received funds from Novo Nordisk for conducting the coding of qualitative data. Dr. Kalra has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Wens has participated on the advisory panels of AstraZeneca, Bristol-Myers Squibb Co, and Eli Lilly and Co and has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Kokoszka has received grants, speaking honoraria, and travel expenses from Novo Nordisk; and funding for research from Krka (Poland), Otsuka Pharmaceutical Co, Ltd, and Sumitomo Dainippon Pharma. Mr. Skovlund is an employee of Novo Nordisk A/S, Copenhagen, Denmark. Dr. Peyrot has received research grants and/or consulting fees from AstraZeneca, Bristol-Myers Squibb/Amylin, Calibra, Eli Lilly, Novo Nordisk, and Roche/Genentech; speaking honoraria from Novo Nordisk; and financial support from Novo Nordisk for his participation as the principal investigator of the DAWN2 study; and he has participated on advisory panels of Eli Lilly, GlaxoSmithKline, and Novo Nordisk. The authors have indicated that they have no other conflicts of interest with regard to the content of this article.

Publisher Copyright:
© 2015 The Authors.

ASJC Scopus Subject Areas

Pharmacology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clinthera.2015.06.010

Fingerprint

Dive into the research topics of '"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)'. Together they form a unique fingerprint.

Cite this

Stuckey, H. L., Vallis, M., Kovacs Burns, K., Mullan-Jensen, C. B., Reading, J. M., Kalra, S., Wens, J., Kokoszka, A., Skovlund, S. E., & Peyrot, M. (2015). "I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study). Clinical Therapeutics, 37(9), 1986-1998.e12. Article 2620. https://doi.org/10.1016/j.clinthera.2015.06.010

"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study). / Stuckey, Heather L.; Vallis, Michael; Kovacs Burns, Katharina et al.
In: Clinical Therapeutics, Vol. 37, No. 9, 2620, 01.09.2015, p. 1986-1998.e12.

Research output: Contribution to journal › Article › peer-review

Stuckey, HL, Vallis, M, Kovacs Burns, K, Mullan-Jensen, CB, Reading, JM, Kalra, S, Wens, J, Kokoszka, A, Skovlund, SE & Peyrot, M 2015, '"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)', Clinical Therapeutics, vol. 37, no. 9, 2620, pp. 1986-1998.e12. https://doi.org/10.1016/j.clinthera.2015.06.010

Stuckey HL, Vallis M, Kovacs Burns K, Mullan-Jensen CB, Reading JM, Kalra S et al. "I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study). Clinical Therapeutics. 2015 Sept 1;37(9):1986-1998.e12. 2620. doi: 10.1016/j.clinthera.2015.06.010

@article{722209b858ee4ac3a63de2b92e6f7f32,

title = "{"}I Do My Best To Listen to Patients{"}: Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)",

abstract = "Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who {"}tells{"} to one who {"}listens{"} to PWD. Some ways that HCPs can {"}listen{"} to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.",

author = "Stuckey, {Heather L.} and Michael Vallis and {Kovacs Burns}, Katharina and Mullan-Jensen, {Christine B.} and Reading, {Jean M.} and Sanjay Kalra and Johan Wens and Andrzej Kokoszka and Skovlund, {S{\o}ren E.} and Mark Peyrot",

note = "Funding Information: Novo Nordisk Inc funded the DAWN2 study. Dr. Stuckey has received compensation from Novo Nordisk for developing the DAWN2 coding scheme, training/supervising coders, and conducting qualitative analysis, as well as travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Vallis has received research funding from AbbVie Inc and Pfizer Inc, and speaking honoraria from AbbVie; Bayer Pharmaceuticals Corp; Becton, Dickinson, and Co; Merck & Co, Inc; Novo Nordisk; and The Sanofi-Aventis Group. Dr. Burns has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Mullan-Jensen{\textquoteright}s salary is paid by Novo Nordisk A/S, Copenhagen, Denmark. Ms. Reading has received funds from Novo Nordisk for conducting the coding of qualitative data. Dr. Kalra has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Wens has participated on the advisory panels of AstraZeneca, Bristol-Myers Squibb Co, and Eli Lilly and Co and has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Kokoszka has received grants, speaking honoraria, and travel expenses from Novo Nordisk; and funding for research from Krka (Poland), Otsuka Pharmaceutical Co, Ltd, and Sumitomo Dainippon Pharma. Mr. Skovlund is an employee of Novo Nordisk A/S, Copenhagen, Denmark. Dr. Peyrot has received research grants and/or consulting fees from AstraZeneca, Bristol-Myers Squibb/Amylin, Calibra, Eli Lilly, Novo Nordisk, and Roche/Genentech; speaking honoraria from Novo Nordisk; and financial support from Novo Nordisk for his participation as the principal investigator of the DAWN2 study; and he has participated on advisory panels of Eli Lilly, GlaxoSmithKline, and Novo Nordisk. The authors have indicated that they have no other conflicts of interest with regard to the content of this article. Publisher Copyright: {\textcopyright} 2015 The Authors.",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.clinthera.2015.06.010",

language = "English",

volume = "37",

pages = "1986--1998.e12",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "9",

}

TY - JOUR

T1 - "I Do My Best To Listen to Patients"

T2 - Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)

AU - Stuckey, Heather L.

AU - Vallis, Michael

AU - Kovacs Burns, Katharina

AU - Mullan-Jensen, Christine B.

AU - Reading, Jean M.

AU - Kalra, Sanjay

AU - Wens, Johan

AU - Kokoszka, Andrzej

AU - Skovlund, Søren E.

AU - Peyrot, Mark

N1 - Funding Information: Novo Nordisk Inc funded the DAWN2 study. Dr. Stuckey has received compensation from Novo Nordisk for developing the DAWN2 coding scheme, training/supervising coders, and conducting qualitative analysis, as well as travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Vallis has received research funding from AbbVie Inc and Pfizer Inc, and speaking honoraria from AbbVie; Bayer Pharmaceuticals Corp; Becton, Dickinson, and Co; Merck & Co, Inc; Novo Nordisk; and The Sanofi-Aventis Group. Dr. Burns has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Mullan-Jensen’s salary is paid by Novo Nordisk A/S, Copenhagen, Denmark. Ms. Reading has received funds from Novo Nordisk for conducting the coding of qualitative data. Dr. Kalra has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Wens has participated on the advisory panels of AstraZeneca, Bristol-Myers Squibb Co, and Eli Lilly and Co and has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Kokoszka has received grants, speaking honoraria, and travel expenses from Novo Nordisk; and funding for research from Krka (Poland), Otsuka Pharmaceutical Co, Ltd, and Sumitomo Dainippon Pharma. Mr. Skovlund is an employee of Novo Nordisk A/S, Copenhagen, Denmark. Dr. Peyrot has received research grants and/or consulting fees from AstraZeneca, Bristol-Myers Squibb/Amylin, Calibra, Eli Lilly, Novo Nordisk, and Roche/Genentech; speaking honoraria from Novo Nordisk; and financial support from Novo Nordisk for his participation as the principal investigator of the DAWN2 study; and he has participated on advisory panels of Eli Lilly, GlaxoSmithKline, and Novo Nordisk. The authors have indicated that they have no other conflicts of interest with regard to the content of this article. Publisher Copyright: © 2015 The Authors.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who "tells" to one who "listens" to PWD. Some ways that HCPs can "listen" to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.

AB - Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who "tells" to one who "listens" to PWD. Some ways that HCPs can "listen" to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84941184441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941184441&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2015.06.010

DO - 10.1016/j.clinthera.2015.06.010

M3 - Article

C2 - 26169765

AN - SCOPUS:84941184441

SN - 0149-2918

VL - 37

SP - 1986-1998.e12

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 9

M1 - 2620

ER -

"I Do My Best To Listen to Patients": Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)

Abstract

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this